Post-hoc analyses revealed that the proportion of females was higher in PREVENT-AD and ROSMAP compared to ADNI (p’s ≤ 1.0 × 10−8) and that the proportion of APOE-ε4 carriers was significantly different between all cohorts (p’s ≤ 5.0 × 10−7). Here, APOE is linked to Alzheimer disease.